Are you looking for investment opportunities in healthtech to shape the future of precision medicine? We at DBI are unleashing the huge potential of analyzing exhaled breath by applying machine learning algorithms. We provide non-invasive solutions for early diagnosis of diseases and therapeutic drug monitoring – enabling better treatment by precision medicine. If you share our vision to advance precision medicine and improve people’s health, invest in us!

• Cutting edge technology
• DBI-EPIbreath^® test, CE-certified under IVDD
• IP with exclusive license in place, strong pipeline
• Worldwide marketing and sales strategy
• Contracts with international pharma & healthtech companies

Register to receive the DBI teaser slide deck!